No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Ame Company For Medical Supplies operates as a distributor and marketer of medical products specifically designed for the aesthetic market throughout Saudi Arabia. Its comprehensive product catalog features a variety of key offerings, including Teoxane, a line of injectable hyaluronic acid-based dermal fillers formulated to reduce wrinkles on the face and neck. The company also provides advanced medical laser systems, innovative therapeutic solutions, and various botulinum products. Furthermore, their portfolio encompasses Magellan, an autologous concentration system for delivering focused platelets and cells at the point of care, as well as MINT, an absorbable polydioxanone barbed suture used for soft tissue approximation. Established in 2005, the firm is headquartered in Jeddah, Saudi Arabia.
www.ame.med.saNo one on the platform currently holds 9527.SR.
No tracked institution reports a position in 9527.SR as of their last filing.
No one on the platform has traded 9527.SR yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 19.3% | 30.8% | — | — | — | |
| Rev. Growth % | 22.8% | 20.2% | ||||
| Profit Margin % | 11.5% | 14.5% | ||||
| Free Cash Flow Margin % | -8.8% | 4.5% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $91M | +14.7% | $8.40 | $8.40–$8.40 | — | 1 |
| 2027 | $391M | +327.5% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 9527.SRAlf Meem Yaa for Medical Supplies and Equipment Company | $66.75 | +1.29% | $467M | — |
| 4014.SRScientific and Medical Equipment House | $26.74 | +0.91% | $802M | — |
| 9518.SRCanadian General Medical Center Complex Company | $9.05 | +2.96% | $697M | — |
| 9530.SRArabian International Healthcare Holding Company | $16.32 | -2.63% | $323M | — |
| 9546.SRNaba Alsaha Medical Services Company | $24.00 | +0.00% | $504M | — |
| 9574.SRProfessional Medical Expertise Co. | $85.00 | -1.68% | $298M | — |
| 9587.SRLana Medical Co. | $2.01 | +0.00% | $109M | — |
Source: Financial Modeling Prep · peers by sector/industry